106 related articles for article (PubMed ID: 2547048)
41. Primary osteosarcoma of the breast.
Remadi S; Doussis-Anagnostopoulu I; Mac Gee W
Pathol Res Pract; 1995 Jun; 191(5):471-4; discussion 475-7. PubMed ID: 7479366
[TBL] [Abstract][Full Text] [Related]
42. Vimentin as a tumour marker.
Thomas K; Mayston V
Histopathology; 1987 Sep; 11(9):991. PubMed ID: 2822564
[No Abstract] [Full Text] [Related]
43. Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.
Gerdes J; Lelle RJ; Pickartz H; Heidenreich W; Schwarting R; Kurtsiefer L; Stauch G; Stein H
J Clin Pathol; 1986 Sep; 39(9):977-80. PubMed ID: 3020096
[TBL] [Abstract][Full Text] [Related]
44. Transferrin receptor (TrfR) expression in breast carcinoma and its possible relationship to prognosis. An immunohistochemical study.
Wrba F; Ritzinger E; Reiner A; Holzner JH
Virchows Arch A Pathol Anat Histopathol; 1986; 410(1):69-73. PubMed ID: 3024390
[TBL] [Abstract][Full Text] [Related]
45. Histochemically demonstrable enzyme activities and their independence of the hormone receptor content in female breast carcinoma.
Partanen S; Syrjänen K
Histopathology; 1982 Nov; 6(6):771-7. PubMed ID: 6298092
[TBL] [Abstract][Full Text] [Related]
46. Collagen composition in the ductal infiltrating carcinoma of human breast.
Minafra S; Minafra IP; Tomasino RM; Sciarrino S
Cell Biol Int Rep; 1984 Jan; 8(1):79-85. PubMed ID: 6323035
[TBL] [Abstract][Full Text] [Related]
47. Intracranial tumours in budgerigars.
Suchy A; Weissenböck H; Schmidt P
Avian Pathol; 1999 Apr; 28(2):125-30. PubMed ID: 26911498
[TBL] [Abstract][Full Text] [Related]
48. Tissue proteins in breast cancer, as studied by use of two-dimensional electrophoresis.
Stastny J; Prasad R; Fosslien E
Clin Chem; 1984 Dec; 30(12 Pt 1):1914-8. PubMed ID: 6094037
[TBL] [Abstract][Full Text] [Related]
49. Immunostaining of ductal breast carcinomas with the monoclonal-antibody-h.
Arvanitis D; Kouklis P; Demoro G; Goutas N; Kittas C; Szuchet S
Oncol Rep; 1995 Nov; 2(6):991-5. PubMed ID: 21597840
[TBL] [Abstract][Full Text] [Related]
50. Breast cancer: young, old, and very old. A preliminary report.
Hartveit F; Maehle BO
Breast Cancer Res Treat; 1988 Oct; 12(2):205-11. PubMed ID: 3242649
[TBL] [Abstract][Full Text] [Related]
51. Higher serum concentrations of vimentin and DAKP1 are associated with aggressive breast tumour phenotypes in Ghanaian women.
Arko-Boham B; Lomotey JT; Tetteh EN; Tagoe EA; Aryee NA; Owusu EA; Okai I; Blay RM; Clegg-Lamptey JN
Biomark Res; 2017; 5():21. PubMed ID: 28616237
[TBL] [Abstract][Full Text] [Related]
52. Total Flavonoids of Litchi Seed Attenuate Prostate Cancer Progression
Chang M; Zhu D; Chen Y; Zhang W; Liu X; Li XL; Cheng Z; Su Z; Zhang J; Lu Y; Guo H
Front Pharmacol; 2021; 12():758219. PubMed ID: 34630125
[TBL] [Abstract][Full Text] [Related]
53. Smudge cells percentage on blood smear is a reliable prognostic marker in chronic lymphocytic leukemia.
Sall A; Seck M; Fall S; Sall FB; Faye BF; Ndiaye FS; Gadji M; Diop S; Touré AO; Raphaël M
Hematol Transfus Cell Ther; 2022; 44(1):63-69. PubMed ID: 34116931
[TBL] [Abstract][Full Text] [Related]
54. Coexpression of FOXK1 and vimentin promotes EMT, migration, and invasion in gastric cancer cells.
Zhang H; Wu X; Xiao Y; Wu L; Peng Y; Tang W; Liu G; Sun Y; Wang J; Zhu H; Liu M; Zhang W; Dai W; Jiang P; Li A; Li G; Xiang L; Liu S; Wang J
J Mol Med (Berl); 2019 Feb; 97(2):163-176. PubMed ID: 30483822
[TBL] [Abstract][Full Text] [Related]
55. Identification of a Subtype of Poorly Differentiated Invasive Ductal Carcinoma of the Breast Based on Vimentin and E-cadherin Expression.
Orlandini LF; Reis FJCD; da Silveira WA; Tiezzi MG; de Andrade JM; Ribeiro-Silva A; Deaton R; Bosland M; Tiezzi DG
Rev Bras Ginecol Obstet; 2018 Dec; 40(12):779-786. PubMed ID: 30359996
[TBL] [Abstract][Full Text] [Related]
56. BHX, a novel pyrazoline derivative, inhibits breast cancer cell invasion by reversing the epithelial-mesenchymal transition and down-regulating Wnt/β-catenin signalling.
Bao H; Zhang Q; Zhu Z; Xu H; Ding F; Wang M; Du S; Du Y; Yan Z
Sci Rep; 2017 Aug; 7(1):9153. PubMed ID: 28831201
[TBL] [Abstract][Full Text] [Related]
57. Epithelial Mesenchymal Transition (EMT) in Metastatic Breast Cancer in Omani Women.
Lakhtakia R; Aljarrah A; Furrukh M; Ganguly SS
Cancer Microenviron; 2017 Dec; 10(1-3):25-37. PubMed ID: 28526992
[TBL] [Abstract][Full Text] [Related]
58. Biomarkers for EMT and MET in breast cancer: An update.
Liu F; Gu LN; Shan BE; Geng CZ; Sang MX
Oncol Lett; 2016 Dec; 12(6):4869-4876. PubMed ID: 28105194
[TBL] [Abstract][Full Text] [Related]
59. A photodynamic bifunctional conjugate for prostate cancer: an in vitro mechanistic study.
Rapozzi V; Varchi G; Della Pietra E; Ferroni C; Xodo LE
Invest New Drugs; 2017 Feb; 35(1):115-123. PubMed ID: 27726093
[TBL] [Abstract][Full Text] [Related]
60. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
